Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
01 1NURAY CHEMICALS PRIVATE LIMITED
02 1Cohance Lifesciences Limited
03 1AX Pharmaceutical Corp
04 1Atul Ltd
05 1DARMERICA, LLC
06 2Dipharma Francis Srl
07 1Fagron Inc
08 1LETCO MEDICAL, LLC
09 1Lundbeck Pharmaceuticals Italy S.p.A.
10 1Medilux Laboratories Private Limited
11 3Professional Compounding Centers of America dba PCCA
12 1SMS Lifesciences India Limited
13 1Sai Life Sciences Limited
14 1Spectrum Laboratory Products, Inc.
01 4DAPSONE
02 12Dapsone
03 1Dapsone Micronized
01 1Canada
02 1Denmark
03 6India
04 2Italy
05 1Netherlands
06 3U.S.A
07 3United Kingdom
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-033
Start Marketing Date : 2024-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 76072-1018
Start Marketing Date : 2019-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0645
Start Marketing Date : 2018-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0649
Start Marketing Date : 2018-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1042
Start Marketing Date : 2021-06-07
End Marketing Date : 2027-01-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 45562-1120
Start Marketing Date : 2001-03-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 50218-008
Start Marketing Date : 2019-03-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0083
Start Marketing Date : 2019-05-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 14474-026
Start Marketing Date : 2012-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-2439
Start Marketing Date : 2020-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Dapsone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dapsone, including repackagers and relabelers. The FDA regulates Dapsone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dapsone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dapsone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dapsone supplier is an individual or a company that provides Dapsone active pharmaceutical ingredient (API) or Dapsone finished formulations upon request. The Dapsone suppliers may include Dapsone API manufacturers, exporters, distributors and traders.
click here to find a list of Dapsone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dapsone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dapsone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dapsone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dapsone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dapsone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dapsone suppliers with NDC on PharmaCompass.
We have 14 companies offering Dapsone
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
